About Us

We are driven to make medicines that matter

Our team includes expert scientists and leaders skilled in advancing programs from discovery through development, including deep experience in biology, protein sciences and antibody engineering. In partnership with our distinguished advisors and investors, we are ready to be the force that changes what is possible for protein degradation medicines.

Leadership Team


Scientific Founder

Advisors

Steve Davidsen, Ph.D.

Scientific Advisor; Former Abbvie

Jorge DiMartino, M.D., Ph.D.

Chief Medical Officer, Plexium

Michael Kavanaugh, M.D.​

Founding Advisor; Former CytomX, Novartis

Henry Lowman, Ph.D.

Scientific Advisor; Former Genentech

Arthur Weiss, M.D., Ph.D.

Distinguished Professor, UC San Francisco

Investors